Old Web
English
Sign In
Acemap
>
Paper
>
Pharmacokinetics, pharmacodynamics, and safety of moss agalactosidase A in patients with Fabry disease
Pharmacokinetics, pharmacodynamics, and safety of moss agalactosidase A in patients with Fabry disease
2018
Julia B. Hennermann
Laila Arash-Kaps
György Fekete
Andreas Schaaf
Andreas Busch
Thomas Frischmith
Keywords:
Pharmacodynamics
Fabry disease
Biology
Pharmacokinetics
Pharmacology
Internal medicine
Gastroenterology
Genetics
in patient
Diabetes mellitus
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]